Nufymco (ranibizumab-leyk)
Biosimilar
- Region
- 🇺🇸 US
- Active substance
- ranibizumab-leyk
- Company
- Formycon Ag
- Status
- Approved
- FDA approval
- Thu 18 Dec 2025
- Designations
- Biosimilar
- Application
- BLA761473
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Thu 18 Dec 2025🇺🇸 FDA approval
FDA approves biosimilar Nufymco (ranibizumab-leyk)
Formycon Ag; BLA761473; Biosimilar; injection · source
Follow Nufymco
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.